A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma
Clinical trial NCT03244306 · COMPLETED
Trial details
- NCT number
- NCT03244306
- Sponsor
- Seattle Children's Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-27
- Primary completion
- 2018-11-14
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.